Literature DB >> 7359014

Impaired elimination of caffeine by oral contraceptive steroids.

R V Patwardhan, P V Desmond, R F Johnson, S Schenker.   

Abstract

The effect of OCS on the disposition and elimination of caffeine was examined. Caffeine (250 mg) was administered orally to 13 healthy males, nine healthy females taking no OCS, and nine healthy females on OCS. The t1/2 (beta) was significantly prolonged in women on OCS (10.7 +/- 3.0 hr vs. 6.2 +/- 1.6) (p less than 0.001) as compared to women taking no OCS. Women on OCS had a significantly lower total plasma clearance (0.79 +/- 0.21 ml/min/kg vs. 1.3 +/- 0.35) and free clearance (1.12 +/- 0.28 ml/min/kg vs. 1.97 +/- 0.57) that women not taking OCS. Volumes of distribution and plasma binding were similar in both groups of females. When women taking no OCS were compared with men, all pharmacokinetic parameters were similar except for volume of distribution, which was significantly larger in the women (p less than 0.05). We conclude that OCS impair the elimination of caffeine.

Entities:  

Keywords:  Biology; Hepatic Effects; Men; Oral Contraceptives; Physiology; Prospective Studies; Research Methodology; Studies; Women

Mesh:

Substances:

Year:  1980        PMID: 7359014

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  42 in total

Review 1.  Caffeine and endurance performance.

Authors:  M A Tarnopolsky
Journal:  Sports Med       Date:  1994-08       Impact factor: 11.136

Review 2.  The impact of caffeine on vasodilator stress perfusion studies.

Authors:  Andre C Lapeyre; Tauqir Y Goraya; Donald L Johnston; Raymond J Gibbons
Journal:  J Nucl Cardiol       Date:  2004 Jul-Aug       Impact factor: 5.952

3.  Effects of moderate exercise on the pharmacokinetics of caffeine.

Authors:  K Collomp; F Anselme; M Audran; J P Gay; J L Chanal; C Prefaut
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

4.  Effect of oral contraceptive steroids on the pharmacokinetics of phenprocoumon.

Authors:  H Mönig; C Baese; H T Heidemann; E E Ohnhaus; H M Schulte
Journal:  Br J Clin Pharmacol       Date:  1990-07       Impact factor: 4.335

Review 5.  Practicing safe SPECT: caffeine abstinence in nuclear myocardial perfusion imaging.

Authors:  Kristina E Powles; Renee C Hessian; Terrence D Ruddy
Journal:  J Nucl Cardiol       Date:  2008 Sep-Oct       Impact factor: 5.952

Review 6.  Clinical pharmacokinetics of non-opiate abused drugs.

Authors:  U Busto; R Bendayan; E M Sellers
Journal:  Clin Pharmacokinet       Date:  1989-01       Impact factor: 6.447

7.  Sustaining executive functions during sleep deprivation: A comparison of caffeine, dextroamphetamine, and modafinil.

Authors:  William D S Killgore; Ellen T Kahn-Greene; Nancy L Grugle; Desiree B Killgore; Thomas J Balkin
Journal:  Sleep       Date:  2009-02       Impact factor: 5.849

8.  Mechanistic pharmacokinetic modelling of ephedrine, norephedrine and caffeine in healthy subjects.

Authors:  C Csajka; C A Haller; N L Benowitz; D Verotta
Journal:  Br J Clin Pharmacol       Date:  2005-03       Impact factor: 4.335

9.  A comparison of the effects of caffeine following abstinence and normal caffeine use.

Authors:  Merideth A Addicott; Paul J Laurienti
Journal:  Psychopharmacology (Berl)       Date:  2009-09-24       Impact factor: 4.530

10.  Maternal caffeine consumption and risk of congenital limb deficiencies.

Authors:  Lei Chen; Erin M Bell; Marilyn L Browne; Charlotte M Druschel; Paul A Romitti; Rebecca J Schmidt; Trudy L Burns; Roxana Moslehi; Richard S Olney
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.